BSX
NYSE · Health Care
Boston Scientific Corp
$45.60
+1.27 (+2.86%)
BSX News13 articles
Amazon Ousts Walmart to Top Fortune 500, Reshaping Corporate Peeking Order
Amazon has claimed the top spot on the 2026 Fortune 500, ending Walmart's 13-year run and signaling a shift in corporate power driven by e-commerce, cloud computing, and healthcare.
Amazon Ousts Walmart as Fortune 500 Leader; Regional Giants Shine
Amazon unseats Walmart as Fortune 500 No. 1, breaking a 13-year streak. Erie Insurance rises, New Jersey boasts 15 firms, and New England has over 20 companies on the list.
Medtronic Stock Edges Up on Earnings Beat, Tariff Warning Looms
Medtronic shares slipped 0.32% to $81.67 Friday after a post-earnings rally, as strong Q4 revenue growth and a dividend hike were offset by a $250 million tariff hit and profit guidance below consensus.
Medtronic Surges on Strong Heart-Device Sales, But 2027 Profit Outlook Caps Gains
Medtronic shares surged 5.1% after beating Q4 estimates, fueled by 78% cardiac ablation growth, but gains were capped by a weak 2027 profit outlook and tariff concerns.
Boston Scientific Tumbles 16% on Watchman Slowdown; Focus Shifts to Monday's Reaction
Boston Scientific shares fell 16.4% last week after CEO Michael Mahoney warned of declining Watchman usage and flat growth through Q3. Wells Fargo downgraded the stock and slashed its price target.
Medtronic Stock Drops 6% Ahead of Earnings Report
Medtronic shares fell 6.1% last week to $73.81 ahead of its fiscal Q4 earnings on June 3. Options imply a 4.1% move. The company recently agreed to buy SPR Therapeutics for $650 million.
Boston Scientific Plunges to Two-Year Low on Watchman Slowdown
Boston Scientific shares fell 10% to a two-year low after CEO Michael Mahoney flagged slower use of its Watchman heart implant, raising growth concerns.
Medtronic Hovers Near 52-Week Low as Market Awaits Earnings
Medtronic shares closed at $76.15, near their 52-week low, as broader market weakness weighed ahead of the company's June 3 earnings report.
Tech Stocks Drive Market Gains Amid Ceasefire Relief and Earnings Strength
U.S. stocks climbed Wednesday, with the Nasdaq leading gains as technology shares rallied following an extended Iran ceasefire and a wave of corporate earnings. Oil prices remained elevated near $100 a barrel.
Hologic CEO to Depart as $18.3B Private Equity Acquisition Nears Completion
Hologic announced CEO Steve MacMillan will step down once the company's $18.3 billion acquisition by Blackstone and TPG finalizes, expected around April 7. The deal will take the women's health technology firm private.
Boston Scientific Stock Rebounds on Positive Farapulse Data, CHAMPION-AF Trial Looms
Boston Scientific shares recovered slightly after a recent sell-off, supported by new long-term data for its Farapulse ablation system. Investor focus now shifts to the upcoming CHAMPION-AF trial results expected in late March.
Boston Scientific Shares Extend Decline Amid Electrophysiology Concerns
Boston Scientific stock fell 2.6% in Monday trading, continuing last week's selloff as investors scrutinize the company's heart-rhythm device segment and Watchman demand.
P&G's Gillette Commits $1 Billion to New Boston HQ Amid Growth Challenges
Procter & Gamble's Gillette brand is investing close to $1 billion to establish a new global headquarters and research hub in South Boston, maintaining its commercial and R&D presence in the city while shifting manufacturing to Andover in 2026.